ENLV
Enlivex Therapeutics Ltd

7,119
Mkt Cap
$23.3M
Volume
923,533.00
52W High
$2.10
52W Low
$0.8313
PE Ratio
-1.74
ENLV Fundamentals
Price
$0.9289
Prev Close
$0.959
Open
$0.99
50D MA
$1.04
Beta
0.70
Avg. Volume
11.57M
EPS (Annual)
-$0.7319
P/B
1.29
Rev/Employee
$0.00
Loading...
Loading...
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
36

Frequently Asked Questions

What is Market Cap of Enlivex Therapeutics Ltd?
What is the 52-week high for Enlivex Therapeutics Ltd?
What is the 52-week low for Enlivex Therapeutics Ltd?
What is Enlivex Therapeutics Ltd stock price today?
What was Enlivex Therapeutics Ltd stock price yesterday?
What is the PE ratio of Enlivex Therapeutics Ltd?
What is the Price-to-Book ratio of Enlivex Therapeutics Ltd?
What is the 50-day moving average of Enlivex Therapeutics Ltd?
How many employess does Enlivex Therapeutics Ltd has?

Latest ENLV News

View

Advertisement|Remove ads.

Advertisement|Remove ads.